Application no. and date | 16733600.7 (espacenet) (Federated) (European Patent Register), 20160701 | Patent/reg. no. and date | DK/EP 3317284, 20191030 | Publication date | 20180509 | Priority no. and date | US 201562188029 P, 20150702 | EP pub. no. and date |
EP 3317284 20180509 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | P70732DK01 | Inventor | HANAN, Emily, c/o Genentech Inc. 1 DNA Way
South San Francisco, California 94080, US, MACLEOD, Calum, 8/9 Spire Green CentreFlex Meadow
Harlow Essex CM19 5TR, GB, BRAUN, Marie-Gabrielle, c/o Genentech Inc. 1 DNA Way
South San Francisco, California 94080, US, HEALD, Robert Andrew, 31 Sheering Mill Lane
Sawbridgeworth Herts CM21 9LW, GB, STABEN, Steven T., c/o Genentech Inc. 1 DNA Way
South San Francisco, California 94080, US, ELLIOTT, Richard, 8/9 Spire Green Centre Flex Meadow
Harlow, Essex CM19 5TR, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/553 (2006.01) , A61P 35/00 (2006.01) , C07D 498/04 (2006.01) | Title | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | Int. application no. | EP2016065455 | Int. publication no. | WO2017001645 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|